Spark Therapeutics (ONCE) News Today → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free ONCE Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisHeadlinesSocial MediaStock AnalysisHeadlinesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineVoyager 1: NASA's longest-running spacecraft back in touch with Earth after five months of silenceuk.news.yahoo.com - April 23 at 10:36 PMTotal eclipse sparks ‘once-in-a-lifetime’ parties across blackout zone: ‘All everyone is talking about’msn.com - April 7 at 2:37 PMSharon Osbourne takes another swipe at X Factor as she admits she's 'very much against' rebootmirror.co.uk - March 27 at 4:13 PMAries Season Is Here, and It's Time to Start Freshsg.finance.yahoo.com - March 16 at 1:43 PMful. Health Introduces Innovative Solution to Help Group Health Plans Right-Size Healthcare Spendingfinance.yahoo.com - March 14 at 7:33 PMFred L. Goldenberg: Drug prices out of controlfinance.yahoo.com - March 13 at 3:57 PMOmega Park inaugurates the Makwa Foundation for the Conservation and Protection of Endangered Speciesfinance.yahoo.com - March 5 at 7:55 AMViking Therapeutics' weight loss drug showed faster results in clinical trials than Ozempic or Wegovy. Here's how it works.ca.news.yahoo.com - February 28 at 2:13 PMPliant Therapeutics Provides Corporate Update and Reports Fourth Quarter 2023 Financial Resultsmarkets.businessinsider.com - February 27 at 7:39 PMBig Money Is Taking Over MDMA-Assisted Therapymsn.com - February 24 at 2:00 PMPCM Trials Acquires EmVenio Research to Create the Most Patient-Centric Model for Hybrid and Decentralized Clinical Trialsfinance.yahoo.com - February 23 at 1:30 PM10 Minor Unsolved Mysteries In The Legend of Zelda With Major Implicationsmsn.com - February 22 at 8:57 PMMitochondrial misfire sparks inflammationmsn.com - February 8 at 2:37 PMAgendia Announces First Patient Enrolled in DEBRA Trial Using MammaPrint®finance.yahoo.com - February 2 at 7:54 PMAdverum Biotechnologies, Inc.: Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officerfinanznachrichten.de - January 29 at 3:45 PMGene therapy for pets: French company buys start-up cofounded by Penn’s Jim Wilsonmsn.com - January 28 at 10:44 PMDr. Carl June on the next biotech breakthroughs and why Philadelphia will lead the waybizjournals.com - January 26 at 2:08 PMBuy Rating Affirmed for Vera Therapeutics on Promising IgAN Drug Trial Resultsmarkets.businessinsider.com - January 25 at 9:08 PMLeukemia Therapeutics Market: Robust Growth Expected with Innovative CAR-T Treatmentsuk.finance.yahoo.com - January 23 at 4:59 PMAward-Winning Biotech Training Program to Begin Recruitment with New Employer Partner in Life Sciencesfinance.yahoo.com - January 17 at 12:13 PMAs Philadelphia life sciences projects slow, developers remain bullish on long-term outlookbizjournals.com - January 7 at 10:16 PMMicroRNA is the master regulator of the genome − researchers are learning how to treat disease by harnessing the way it controls genesmsn.com - January 2 at 10:20 AMOpinion: Bringing psychedelic medicine from the margins to the mainstreammsn.com - January 1 at 5:42 PM'Magical' Theme Park Date Sparks Couple Goalsmsn.com - December 27 at 4:07 PMIn $4 billion deal, Bristol Myers Squibb to buy cancer therapeutics firm RayzeBiomsn.com - December 26 at 3:10 PMLVMH and luxury’s year of changing fortunes set for reverse act in 2024finance.yahoo.com - December 16 at 12:56 PMWhat’s next for CRISPR? A Penn cardiologist wants to edit the genes of people with high cholesterol.msn.com - December 14 at 8:06 AMSmart Immune appoints Dr. Rahim Fandi, M.D, PhD as Chief Medical Officer, strengthening C suite with seasoned oncology expertisefinance.yahoo.com - December 4 at 7:47 AMFoghorn Therapeutics Inc.'s (NASDAQ:FHTX) Price Is Right But Growth Is Lacking After Shares Rocket 27%finance.yahoo.com - December 1 at 8:21 AMAkari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Patel, M.D. to Board of Directorsfinance.yahoo.com - December 1 at 8:21 AMThe CRISPR Era Is Heremsn.com - November 28 at 1:52 PMSchool Stabbing Sparks Unrest In Dublin, 34 Arrested For Riotingmsn.com - November 24 at 9:38 AMCapital One Spark Cash Select Review: Two Options for Businessescnet.com - November 22 at 8:10 PMUnpaid contractors file more than $125M in liens against Discovery Labs as MLP Ventures works to secure financingbizjournals.com - November 21 at 3:11 PMLarimar Therapeutics GAAP EPS of -$0.21 beats by $0.02msn.com - November 14 at 12:00 PMJanux Therapeutics GAAP EPS of -$0.25msn.com - November 8 at 1:12 PMCrescita Therapeutics GAAP EPS of -C$0.06, revenue of C$3.03Mmsn.com - November 8 at 1:12 PMFutures down as Middle East conflict sparks run for safe-haven assetsmsn.com - October 9 at 6:19 PMUS STOCKS-Futures down as Middle East conflict sparks run for safe-haven assetsreuters.com - October 9 at 8:10 AMCovid antivirals lose spark as regulatory scrutiny increasesft.com - October 9 at 8:10 AMGene Therapy Market Size to Reach USD 35.1 Billion By 2032 CAGR: 16.4%. Report By DataHorizzon Researchfinance.yahoo.com - September 26 at 10:28 PMControversial park sign sparks divided reaction online: ‘I need a couple copies of this sign’news.yahoo.com - September 14 at 6:41 PM‘Pain Hustlers’ Review: Emily Blunt Dominates Netflix’s Simplistic Opioid Dramayahoo.com - September 12 at 3:23 AMEXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancersbenzinga.com - September 8 at 7:31 AMSernova Corporation Announces the Appointment of Cynthia Pussinen as CEOmarkets.businessinsider.com - September 5 at 7:37 AMFTSE 100 Live: London blue-chips climb amid big GDP revision, surprise jump in US unemploymentmsn.com - September 1 at 3:36 PMSpark Biomedical Awarded $1.15M Department of Defense Phase II STTR Grant in Partnership with Battelle Memorial Institutebenzinga.com - August 29 at 6:24 PMJim Kenney 1,000 days in: The fine print of the Philly mayor’s promisesmsn.com - August 16 at 3:33 PMCapital One Spark Miles Card review 2023usatoday.com - August 14 at 8:35 PMMD Anderson partners with newly financed biotech to target 'undruggable' cancersbizjournals.com - July 27 at 3:52 AM Get Spark Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCE and its competitors with MarketBeat's FREE daily newsletter. Email Address top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (Ad)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall. Click here now for the full details of this stock that’s set to rocket in the AI revolution… ONCE Media Mentions By Week ONCE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONCE News Sentiment▼0.000.43▲Average Medical News Sentiment ONCE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONCE Articles This Week▼11▲ONCE Articles Average Week Get Spark Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CELZ News TTNP News FRTX News PALI News FNCH News BCDA News TCON News KRBP News ALBT News ELOX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONCE) was last updated on 4/24/2024 by MarketBeat.com Staff From Our Partnerstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spark Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
